[PRISMS Study. Interferon-beta 1a (Rebif) in relapsing multiple sclerosis]

Nervenarzt. 1999 Feb;70(2):182-5. doi: 10.1007/s001150050421.
[Article in German]
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Adjuvants, Immunologic / adverse effects
  • Adult
  • Disability Evaluation
  • Double-Blind Method
  • Female
  • Humans
  • Injections, Subcutaneous
  • Interferon beta-1a
  • Interferon-beta / administration & dosage*
  • Interferon-beta / adverse effects
  • Male
  • Multiple Sclerosis / therapy*
  • Neurologic Examination / drug effects
  • Prospective Studies
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Interferon-beta
  • Interferon beta-1a